Immunovant Inc.

Contributing Author

Recent Articles by Immunovant Inc.

Oct-27	Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025 IMVT GlobeNewswire
Sep-03	Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients IMVT GlobeNewswire
Aug-11	Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025 IMVT GlobeNewswire
May-29	Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 IMVT GlobeNewswire